A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera is a research paper published in Nature (2005). On theSindex it has a DataRank of 1.2. It has been cited 3,542 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.2
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
108.66
Citation Percentile
1.0%
Influential Citations
162
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 1 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 2 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 2 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 3 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 3 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 4 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 4 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 5 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 5 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 6 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 6 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 7 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 7 of MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
Additional file 1 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Additional file 1 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Additional file 2 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Additional file 2 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Additional file 3 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Additional file 3 of Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry